Understanding how certain RNA sequences affect gene expression in mammals
Regulation and Function of Alternative mRNA Isoform Expression in Mammals
This study is looking at how certain parts of genes, called introns and RNA sequences, help control how much of a gene is turned on in mammals, which could lead to new ways to treat genetic conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10761767 on NIH RePORTER |
What this research studies
This research investigates the role of introns and specific RNA sequences in regulating gene expression in mammals. It aims to uncover how intron-mediated enhancement (IME) and exon-mediated activation of transcription starts (EMATS) influence the levels of gene expression. By using advanced techniques, including a library of random sequences and a dual fluorescent reporter system, the study will measure how these RNA features impact gene activity. The findings could lead to new methods for modulating gene expression, which may have significant implications for treating various genetic conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic conditions that may be influenced by gene expression levels.
Not a fit: Patients with conditions unrelated to gene expression or those not affected by RNA processing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide new strategies for controlling gene expression, potentially leading to innovative treatments for genetic disorders.
How similar studies have performed: Previous research has shown promising results in understanding RNA regulation, suggesting that this approach could yield valuable insights.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Burge, Christopher B — Massachusetts Institute of Technology
- Study coordinator: Burge, Christopher B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.